Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Pathology|May 8, 2015
CXCR2 inhibition suppresses acute and chronic pancreatic inflammationColin W Steele, Saadia A Karim, Mona Foth, et al.
Cancer Research|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated MelanomaMona Foth, Wontak Kim, Kayla O'Toole, et al.
Pigment Cell & Melanoma Research|March 21, 2008
Meeting report: fourth international congress of the Society for Melanoma ResearchDavid E Fisher, Estela E Medrano, Martin McMahon, et al.
The Journal of Clinical Investigation|February 18, 2004
Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-RafMartin O Bergo, Bryant J Gavino, Christine Hong, et al.
Developmental Biology|April 28, 2012
E-cadherin regulates the behavior and fate of epithelial stem cells and their progeny in the mouse incisorChun-Ying Li, Wanghee Cha, Hans-Ulrich Luder, et al.
BMC Cancer|December 13, 2025
Cancer in adults with intellectual disability: a systematic review of prevalence and incidenceMartin McMahon, Andrew Wormald, Shauna Walsh, et al.
Pigment Cell & Melanoma Research|August 22, 2008
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survivalRobert A Cartlidge, G R Thomas, Sebastien Cagnol, et al.
Expert Opinion on Therapeutic Targets|September 28, 2005
The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it?John G Shelton, Linda S Steelman, Steve L Abrams, et al.
Elife|August 28, 2019
Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinaseJ Edward van Veen, Michael Scherzer, Julia Boshuizen, et al.
The Journal of Experimental Medicine|January 31, 2023
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibitionMark R Silvis, Dilru Silva, Riley Rohweder, et al.
Pageof 13